Bladder cancer blood and tissue study for new tests and treatments
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study collects samples from people who may have bladder cancer or already have a bladder cancer diagnosis. Those samples will help researchers develop better biomarkers (lab tests) and new therapies in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being seen in clinic for suspected bladder cancer, or you already have bladder cancer
- You can join even if you’re also in other research studies at the same time
- You must have a reason your care team thinks this is bladder cancer (or confirmed bladder cancer)
- If you do not have presumed bladder cancer, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue and blood samples from people diagnosed with early-stage bladder cancer (tumors that have not invaded the bladder muscle). The goal is to use these samples for research that could improve future diagnosis and treatment. It may be an opportunity to contribute to medical research.
This study follows people with bladder cancer (except the very earliest Ta stage) to better understand the disease and improve care. You may be asked for basic health information and consent, and joining does not prevent you from joining other studies.
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
This study collects blood and tissue samples from people with cancer or suspected cancer, or from their blood relatives. Researchers use these samples to better understand cancer and develop new treatments.
This study examines whether a simple blood test can detect cancer DNA (circulating tumor DNA, or ctDNA) in patients with a specific type of bladder cancer. Detecting this DNA in blood may help doctors predict how the cancer will behave and guide future treatment decisions.
This study looks for specific DNA changes in bladder cancer tumors using a precise test. It aims to better understand the disease and may help guide future treatment choices.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.